Rilonacept in Diabetes Mellitus Type 1: Safety Study
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is being done to see if an investigational drug called rilonacept is safe to use
in patients with type 1 diabetes, and if it can slow the loss of the body's ability to
secrete insulin in patients who are still able to make a small amount of insulin.